NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
25.07
-0.69 (-2.68%)
Aug 14, 2025, 11:39 AM - Market open

NAMS Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-165.72-241.6-176.94-22.63-41.79-7.03
Depreciation & Amortization
0.180.110.050.010.010
Other Amortization
----0.16-
Asset Writedown & Restructuring Costs
---87.22-
Stock-Based Compensation
47.833.6224.574.121.24-
Other Operating Activities
16.0481.985.2310.8-0.820.37
Change in Accounts Payable
0.57-12.955.074.816.561.01
Change in Unearned Revenue
-6.28-3.95-8.7118.43--
Change in Other Net Operating Assets
-15.73-15.779.5-12.86-2.09-1.66
Operating Cash Flow
-124.12-158.56-141.2210.67-29.51-7.3
Capital Expenditures
-0.18-0.67-0.02-0.22-0.02-0.02
Investment in Securities
-218.35-62.18----
Investing Cash Flow
-218.54-62.85-0.02-0.22-0.02-0.02
Short-Term Debt Issued
---0.75-13.85
Total Debt Issued
---0.75-13.85
Net Debt Issued (Repaid)
---0.75-13.85
Issuance of Common Stock
468.22661.048.91396.95--
Repurchase of Common Stock
--0.99----
Other Financing Activities
-1.61-0.54--5.79--
Financing Cash Flow
466.61659.518.91391.9184.713.85
Foreign Exchange Rate Adjustments
9.2-6.85.055.25-4.680.03
Net Cash Flow
133.16431.29-127.28407.650.496.56
Free Cash Flow
-124.3-159.24-141.2410.44-29.54-7.32
Free Cash Flow Margin
-194.21%-349.49%-1002.43%10.17%--
Free Cash Flow Per Share
-1.16-1.69-1.720.55-2.69-1.46
Cash Interest Paid
---0.28--
Cash Income Tax Paid
000.03---
Levered Free Cash Flow
-85.03-43.17-7222.7-15.94-
Unlevered Free Cash Flow
-85.03-43.17-7222.88-15.84-
Change in Working Capital
-21.44-32.675.8710.374.47-0.65
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q